JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Hear from renowned rheumatology experts on the latest insights about the application of efficacy and safety data for JAK inhibitors in RA management.

Share

Program Content

Activities

JAK Inhibitors in RA
JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 09, 2023

Expires: January 08, 2024

Activities

JAK Inhibitors in RA
JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making
Video
Congratulations: You achieved a completion on 04/09/2022

Released: January 10, 2023

Expires: February 29, 2024

Faculty

cover img faculity

Vivian P. Bykerk, MD, FRCPC

Director
Inflammatory Arthritis Center of Excellence
Rheumatology Attending
Department of Rheumatology
Hospital for Special Surgery
Professor of Medicine
Division of Rheumatology
Department of Medicine
Weill Cornell Medical Center
New York, New York

cover img faculity

Stanley B. Cohen, MD

Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

cover img faculity

Janet Pope

Professor of Medicine
Division of Rheumatology
Division of Epidemiology and Biostatistics
University of Western Ontario Schulich School of Medicine
Division Head
Rheumatology
St. Joseph’s Health Centre
London, Ontario, Canada

cover img faculity

Vibeke Strand, MD, MACR, FACP

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Biopharmaceutical Consultant
Palo Alto, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

This activity is supported by an educational grant from

Lilly